Product Name:
MEK2-3
Product Number:
ab-nk100-6
Target Full Name: MAPK/ERK protein-serine kinase 2 (MKK2); Dual specificity mitogen-activated protein kinase kinase 2
Target Alias: ERK activator kinase 2; MAP kinase kinase 2; MAP2K2; MAPK,ERK kinase 2; MAPKK2; MKK2; MP2K2; PRKMK2EC; MEK2; PRKMK2; CCDS12120.1; ENSG00000126934
Product Type Specific: MEK2 (MAP2K2) protein kinase pan-specific antibody
Antibody Code: NK100-6
Antibody Target Type: Pan-specific
Protein UniProt: P36507
Protein SigNET: MEK2
Antibody Type: Polyclonal
Antibody Host Species: Rabbit
Antibody Immunogen Source: Human MEK2 (MKK2, MAP2K2) sequence peptide Cat. No.: PE-01AVX90
Antibody Immunogen Sequence: CTLRLNQPGTPTRTAV
Antibody Immunogen Description: Corresponds to amino acid residues T386 to V400; C-terminus.
Production Method: The immunizing peptide was produced by solid phase synthesis on a multipep peptide synthesizer and purified by reverse-phase hplc chromatography. Purity was assessed by analytical hplc and the amino acid sequence confirmed by mass spectrometry analysis. This peptide was coupled to KLH prior to immunization into rabbits. New Zealand White rabbits were subcutaneously injected with KLH-coupled immunizing peptide every 4 weeks for 4 months. The sera from these animals was applied onto an agarose column to which the immunogen peptide was thio-linked. Antibody was eluted from the column with 0.1 M glycine, pH 2.5. Subsequently, the antibody solution was neutralized to pH 7.0 with saturated Tris.
Antibody Modification: Unconjugated. Contact KInexus if you are interest in having the antibody biotinylated or coupled with fluorescent dyes.
Antibody Concentration: 1 mg/ml
Storage Buffer: Phosphate buffered saline pH 7.4, 0.05% Thimerasol
Storage Conditions: For long term storage, keep frozen at -40°C or lower. Stock solution can be kept at +4°C for more than 3 months. Avoid repeated freeze-thaw cycles.
Product Use: Western blotting | Antibody microarray
Antibody Dilution Recommended: 1 µg/ml for immunoblotting
Antibody Potency: Strong immunoreactivity with recombinant human MEK2 on protein dot blots.
Antibody Species Reactivity: This antibody detects the target protein in the following species due to conservation of amino acid sequence: Human | Rhesus Macaque | Rat | Mouse | Platypus | Chicken | Frog.
Antibody Positive Control: The observed molecular mass of the processed target protein on SDS-PAGE gels is reported to be around 43-50 kDa.
Antibody Specificity: Very high
Antibody Cross Reactivity: No immunoreactivity on protein dot blots with recombinant human MEK1, MKK4 and MKK6.
Related Product 1: MEK2 (386-400) antibody blocking peptide (Cat. No.: PE-01AVX90)
Related Product 2: MEKSubtide kinase substrate peptide (Cat. No.: PE-01BIB75)
Related Product 3: MEK2 expression antibody (Cat. No.: AB-NK100-3)
Related Product 4: MEK2 expression antibody (Cat. No.: AB-NK100-4)
Related Product 5: MEK2 expression antibody (Cat. No.: AB-NK100-4P)
Related Product 6: MEK2 expression antibody (Cat. No.: AB-NK100-5)
Scientific Background: MEK2 (MAP2K2) is a 44 kDa Dual specificity protein kinase of the STE group and STE7 family. It functions in the MAP kinase signalling pathway, and plays a role in the regulation of cell growth, adhesion, survival, and differentiation. It is a dual specificity protein kinase which acts as an essential component of the MAP kinase signal transduction pathway. Binding of extracellular ligands such as growth factors, cytokines and hormones to their cell-surface receptors activates Ras and this initiates Raf1 activation. Raf1 then further activates the dual-specificity protein kinases MAP2K1/MEK1 and MAP2K2/MEK2. Both MAP2K1/MEK1 and MAP2K2/MEK2 function specifically in the MAPK/ERK cascade, and catalyze the concomitant phosphorylation of a threonine and a tyrosine residue in a Thr-Glu-Tyr sequence located in the extracellular signal-regulated kinases MAPK3/ERK1 and MAPK1/ERK2, leading to their activation and further transduction of the signal within the MAPK/ERK cascade. Phosphorylation of Ser-218 and Ser-222 in MEK1 activates phosphotransferase activity, whereas Ser-216 phosphorylation is inhibitory. It is highly expressed in various human tissues, including the brain and heart. While both MEK1 and MEK2 are present in mammals, MEK2 is generally considered non-essential for normal mouse embryo development and T-cell lineage development, as its loss can be compensated for by MEK1. Mutations or overactivity in MEK2 are associated with cancer proliferation (e.g., melanoma, colorectal cancer) and developmental disorders like cardiofaciocutaneous syndrome. This description may include information annotated by UniProt and/or Google AI.